Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$15.62
+1.96%
Mkt Cap $1.61B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$43.20
Range $30.00 – $56.00
Implied Upside
+176.7%
Consensus $43.20 vs current $15.62
NASDAQ·Healthcare·Biotechnology
$15.62
+1.96%
Mkt Cap $1.61B
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$43.20
Range $30.00 – $56.00
+176.7%
Consensus $43.20 vs current $15.62